(Total Views: 700)
Posted On: 01/10/2023 11:04:04 AM
Post# of 153941
Re: Cassandra X #132311
As I wrote in msg 120966, I still don't know why this isn't feasible -
"I would love to hear of a limited licensing agreement with someone like Samsung for all indications in a limited market and a wad of upfront money for that privilege. That would leave Cytodyn and its intellectual property intact and would reveal Cytodyn's true worth."
Cytodyn has a lot of baggage and bills but that wouldn't encumber a licensee at all and would be money for Cytodyn in a very unencumbered way.
Should the licensee do trials that prove Leronlimab's efficacy, Cytodyn could negotiate for that precious data for approval in the US and elsewhere for itself.
Seems like Win-Win to me!
"I would love to hear of a limited licensing agreement with someone like Samsung for all indications in a limited market and a wad of upfront money for that privilege. That would leave Cytodyn and its intellectual property intact and would reveal Cytodyn's true worth."
Cytodyn has a lot of baggage and bills but that wouldn't encumber a licensee at all and would be money for Cytodyn in a very unencumbered way.
Should the licensee do trials that prove Leronlimab's efficacy, Cytodyn could negotiate for that precious data for approval in the US and elsewhere for itself.
Seems like Win-Win to me!
(2)
(0)
